Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hart Biologicals develops and manufactures commercialized diagnostic reagents and devices for haemostasis and platelet function analysis. Their products are widely used in clinical laboratories globally for coagulation testing, INR monitoring, Clauss fibrinogen assays, and platelet aggregation studies. The company has a strong reputation for quality-driven solutions with ISO accreditation. No therapeutics or clinical trial results; all products are diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hart Biologicals.